292 related articles for article (PubMed ID: 15592049)
1. Effects of urinary prothrombin fragment 1 in the formation of calcium oxalate calculus.
Liu J; Chen J; Wang T; Wang S; Ye Z
J Urol; 2005 Jan; 173(1):113-6. PubMed ID: 15592049
[TBL] [Abstract][Full Text] [Related]
2. Decreased inhibitory activity of prothrombin to calcium oxalate crystallization by specific chemical modification of its gamma-carboxyglutamic acid residues.
Liu J; Wang T; Chen J; Wang S; Ye Z
Urology; 2006 Jan; 67(1):201-3. PubMed ID: 16413375
[TBL] [Abstract][Full Text] [Related]
3. Effect of prothrombin and its activation fragments on calcium oxalate crystal growth and aggregation in undiluted human urine in vitro: relationship between protein structure and inhibitory activity.
Grover PK; Ryall RL
Clin Sci (Lond); 2002 Apr; 102(4):425-34. PubMed ID: 11914105
[TBL] [Abstract][Full Text] [Related]
4. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
Ryall RL; Chauvet MC; Grover PK
BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
[TBL] [Abstract][Full Text] [Related]
5. The effect of warfarin therapy on the charge properties of urinary prothrombin fragment 1 and crystallization of calcium oxalate in undiluted human urine.
Buchholz NP; Kim DS; Grover PK; Dawson CJ; Ryall RL
J Bone Miner Res; 1999 Jun; 14(6):1003-12. PubMed ID: 10352110
[TBL] [Abstract][Full Text] [Related]
6. The hole truth: intracrystalline proteins and calcium oxalate kidney stones.
Ryall RL; Fleming DE; Grover PK; Chauvet M; Dean CJ; Marshall VR
Mol Urol; 2000; 4(4):391-402. PubMed ID: 11156707
[TBL] [Abstract][Full Text] [Related]
7. Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells.
Kumar V; Farell G; Lieske JC
J Urol; 2003 Jul; 170(1):221-5. PubMed ID: 12796693
[TBL] [Abstract][Full Text] [Related]
8. Calcium phosphate crystal-associated proteins: alpha2-HS-glycoprotein, prothrombin F1, and osteopontin.
Nishio S; Hatanaka M; Takeda H; Aoki K; Iseda T; Iwata H; Yokoyama M
Mol Urol; 2000; 4(4):383-90. PubMed ID: 11156706
[TBL] [Abstract][Full Text] [Related]
9. Sialylation of urinary prothrombin fragment 1 is implicated as a contributory factor in the risk of calcium oxalate kidney stone formation.
Webber D; Radcliffe CM; Royle L; Tobiasen G; Merry AH; Rodgers AL; Sturrock ED; Wormald MR; Harvey DJ; Dwek RA; Rudd PM
FEBS J; 2006 Jul; 273(13):3024-37. PubMed ID: 16817853
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of calcium oxalate crystal growth and aggregation by prothrombin and its fragments in vitro: relationship between protein structure and inhibitory activity.
Grover PK; Ryall RL
Eur J Biochem; 1999 Jul; 263(1):50-6. PubMed ID: 10429186
[TBL] [Abstract][Full Text] [Related]
11. Blood coagulation proteins and urolithiasis are linked: crystal matrix protein is the F1 activation peptide of human prothrombin.
Stapleton AM; Ryall RL
Br J Urol; 1995 Jun; 75(6):712-9. PubMed ID: 7613825
[TBL] [Abstract][Full Text] [Related]
12. Intracrystalline proteins and urolithiasis: a synchrotron X-ray diffraction study of calcium oxalate monohydrate.
Fleming DE; Van Riessen A; Chauvet MC; Grover PK; Hunter B; van Bronswijk W; Ryall RL
J Bone Miner Res; 2003 Jul; 18(7):1282-91. PubMed ID: 12854839
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein calcium oxalate crystal growth inhibitor in urine.
Worcester EM; Nakagawa Y; Coe FL
Miner Electrolyte Metab; 1987; 13(4):267-72. PubMed ID: 3306319
[TBL] [Abstract][Full Text] [Related]
14. Calcium phosphate crystal-associated proteins: alpha-2-HS-glycoprotein, prothrombin fragment 1 and osteopontin.
Nishio S; Hatanaka M; Takeda H; Aoki K; Iseda T; Iwata H; Yokoyama M
Int J Urol; 2001 Aug; 8(8):S58-62. PubMed ID: 11555022
[TBL] [Abstract][Full Text] [Related]
15. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
Atmani F; Lacour B; Daudon M
Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564
[TBL] [Abstract][Full Text] [Related]
16. Association of urinary macromolecules with calcium oxalate crystals induced in vitro in normal human and rat urine.
Atmani F; Opalko FJ; Khan SR
Urol Res; 1996; 24(1):45-50. PubMed ID: 8966841
[TBL] [Abstract][Full Text] [Related]
17. Urine protein markers distinguish stone-forming from non-stone-forming relatives of calcium stone formers.
Bergsland KJ; Kelly JK; Coe BJ; Coe FL
Am J Physiol Renal Physiol; 2006 Sep; 291(3):F530-6. PubMed ID: 16622176
[TBL] [Abstract][Full Text] [Related]
18. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
19. Crystal matrix protein is related to human prothrombin.
Stapleton AM; Simpson RJ; Ryall RL
Biochem Biophys Res Commun; 1993 Sep; 195(3):1199-203. PubMed ID: 8216249
[TBL] [Abstract][Full Text] [Related]
20. A study of crystal matrix extract and urinary prothrombin fragment 1 from a stone-prone and stone-free population.
Durrbaum D; Rodgers AL; Sturrock ED
Urol Res; 2001 Apr; 29(2):83-8. PubMed ID: 11396733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
